ICU后远程医疗照护模式的随机对照试验(WFIT)
本研究为单中心随机对照试验,纳入400例脓毒症和/或急性呼吸衰竭ICU患者,评估ICU后远程医疗照护模式的成本效益与临床疗效。干预组在ICU出院后1周和2周接受远程医疗访视并按需持续6个月。结果显示两组总体医疗支出差异无统计学意义,增量净效益为$1,958.29(95%CI -$5,779.56至$9,696.14),再入院、死亡率和生活质量评分相似,但患者报告的院外急诊就诊率干预组更高(2.43 vs 0.97每100患者每月,P=0.03)。
要点
- ICU后远程医疗干预未显示明确的增量净效益
- 干预组患者报告的院外急诊就诊率显著高于对照组(P=0.03)
- 再入院、死亡率和生活质量两组间无显著差异
核心结论
- ICU后远程医疗干预与标准照护相比,总体医疗支出变异大但无明确增量净效益。
研究设计与样本
- 单中心随机对照试验,纳入400例脓毒症和/或急性呼吸衰竭ICU患者,过去一年住院≤2次,且非来自或转至安宁疗护、专业护理机构或长期急性照护医院。
- 干预组在ICU出院后1周和2周接受计划远程医疗访视,并按需持续6个月,由受训于ICU后康复的临床医生提供。
主要发现
- 急诊就诊和住院总体医疗支出均值(SD)为对照组$7,801.10($15,461.03),干预组$8,086.50($17,464.87)。
- 增量净效益为$1,958.29(95%CI -$5,779.56至$9,696.14)。
- 本医疗系统内急诊就诊两组相同,但患者报告的院外医院急诊就诊不同:对照组0.97每100患者每月 vs 干预组2.43每100患者每月(P=0.03)。
- 再入院、死亡率、生活质量评分和总体患者满意度评分两组相似。
临床怎么用
- 该ICU后远程医疗模式未显示明确的成本效益优势,临床推广需谨慎。
- 需关注干预组患者报告院外急诊就诊率较高的情况。
局限性
- 单中心研究,结果外推需谨慎。
- 总体医疗支出变异大,增量净效益置信区间宽。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Survivors of critical illness are at high risk for poor long-term outcomes, including readmissions, reduced quality of life, and mortality. A post-ICU telehealth care model may improve outcomes. Objectives: We sought to evaluate the cost-effectiveness and clinical efficacy of a post-ICU telehealth care model. Methods: We performed a single-center randomized controlled trial of 400 ICU patients with sepsis and/or acute respiratory failure, who had two or fewer hospital admissions in the past year, and who were not admitted from or discharged to hospice, a skilled nursing facility, or a long-term acute care hospital. The intervention group had scheduled telehealth visits at 1 and 2 weeks after ICU discharge and as needed for 6 months with a clinician trained in post-ICU recovery. The primary outcome is the cost-effectiveness of the intervention. Measurements and Main Results: Overall healthcare spending on emergency room (ER) visits and hospitalizations were a mean (SD, in U.S. dollars) $7,801.10 ($15,461.03) in the attention control group versus $8,086.50 ($17,464.87) in the intervention group, with a calculated incremental net benefit of $1,958.29 (-$5,779.56 to $9,696.14). ER visits to our healthcare system were the same between groups, but patient-reported ER visits to outside hospitals were different (0.97 per 100 patients per month in the attention control group vs. 2.43 in the intervention group; P = 0.03). Readmissions, mortality, quality-of-life scores, and overall patient satisfaction scores were similar between groups. Conclusions: This randomized controlled trial of a post-ICU telehealth intervention demonstrated wide variation but no clear incremental net benefit compared with standard care. Clinical trial registered with www.clinicaltrials.gov (NCT04576065).
引用
- Bakhru RN, Flores L, Cain JM, et al. A Randomized Controlled Trial of a Post-ICU Telehealth Care Model (WFIT). Am J Respir Crit Care Med. 2025. PMID: 40532205. doi:10.1164/rccm.202411-2167OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。